Patrick Plewman's Insider Trades & SAST Disclosures
Patrick Plewman's most recent trade in Quest Diagnostics, Inc. was a trade of 81 Common Stock done at an average price of $164.4 . Disclosure was reported to the exchange on April 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Patrick Plewman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | 21 Apr 2025 | 81 | 21,087 (0%) | 0% | 164.4 | 13,318 | Common Stock | |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 166.71 per share. | 26 Mar 2025 | 162 | 20,988 (0%) | 0% | 166.7 | 27,007 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 173.74 per share. | 03 Mar 2025 | 5,674 | 23,430 (0%) | 0% | 173.7 | 985,801 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 2,280 | 21,150 (0%) | 0% | 173.7 | 396,127 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 106 | 17,756 (0%) | 0% | 173.7 | 18,416 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 171.75 per share. | 26 Feb 2025 | 229 | 17,853 (0%) | 0% | 171.8 | 39,331 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 169.71 per share. | 19 Feb 2025 | 320 | 18,082 (0%) | 0% | 169.7 | 54,307 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 7,833 | 7,833 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 2,042 | 18,402 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | 29 Jan 2025 | 57 | 16,345 (0%) | 0% | 158.0 | 9,008 | Common Stock | |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | 21 Oct 2024 | 60 | 16,258 (0%) | 0% | 149.4 | 8,962 | Common Stock | |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | 22 Jul 2024 | 60 | 16,162 (0%) | 0% | 147.0 | 8,818 | Common Stock | |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 126.25 per share. | 22 Apr 2024 | 69 | 16,062 (0%) | 0% | 126.2 | 8,711 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.11 per share. | 26 Mar 2024 | 114 | 15,981 (0%) | 0% | 128.1 | 14,605 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 228 | 16,187 (0%) | 0% | 126.4 | 28,810 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 105 | 16,082 (0%) | 0% | 126.4 | 13,268 | Common Stock |
| Quest Diagnostics, Inc. | Plewman Patrick | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 125.02 per share. | 23 Feb 2024 | 2,388 | 17,284 (0%) | 0% | 125.0 | 298,548 | Common Stock |
| Quest Diagnostics, Inc. | Plewman Patrick | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 23 Feb 2024 | 869 | 16,415 (0%) | 0% | 125.0 | 108,642 | Common Stock |
| Quest Diagnostics, Inc. | Plewman Patrick | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 21 Feb 2024 | 139 | 14,896 (0%) | 0% | 125.0 | 17,378 | Common Stock |
| Quest Diagnostics, Inc. | Plewman Patrick | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 10,190 | 10,190 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 2,446 | 15,035 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Plewman Patrick | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 129.32 per share. | 31 Jan 2024 | 50 | 12,589 (0%) | 0% | 129.3 | 6,466 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 122.83 per share. | 23 Oct 2023 | 52 | 12,492 (0%) | 0% | 122.8 | 6,387 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 144.59 per share. | 25 Jul 2023 | 44 | 12,397 (0%) | 0% | 144.6 | 6,362 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | 24 Apr 2023 | 44 | 12,319 (0%) | 0% | 143.1 | 6,296 | Common Stock | |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.25 per share. | 24 Mar 2023 | 99 | 12,258 (0%) | 0% | 134.3 | 13,291 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 147.86 per share. | 06 Mar 2023 | 2,579 | 13,145 (0%) | 0% | 147.9 | 381,331 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 06 Mar 2023 | 799 | 12,357 (0%) | 0% | 147.9 | 118,140 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 140.69 per share. | 01 Mar 2023 | 90 | 10,566 (0%) | 0% | 140.7 | 12,662 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 7,584 | 7,584 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 1,919 | 10,656 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 23 Feb 2023 | 245 | 8,737 (0%) | 0% | 147.9 | 36,226 | Common Stock |
| Quest Diagnostics, Inc. | Patrick Plewman | SVP for Diagnostic Services | 01 Feb 2023 | 27 | 8,982 (0%) | 0% | 146.7 | 3,962 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges